US Banks Predict Forecasts: Carl Zeiss Meditec Under Pressure!

US banks JPMorgan and Goldman Sachs have taken over their financing for the assets of Carl Zeiss Meditec, a revolving Medizintechnik group. JPMorgan has made the purchase of “Underweight” and assigned a price of 56 euros. Analyst David Adlington said in an industry commentary that the skepticism about the key quarters in this month and the publication on the Geschäftsjahr 2025 was the main group for this negative assessment. Adlington stops the active operation of an employee for a reasonable and indefinite period 12 Perzent unter dem Konsens.

Goldman Sachs has paid the Kursziel for the Carl Zeiss Meditec-Aktien from 63 to 54 Euro and made the purchase at “Sell” prices. Analyst Richard Felton has taken note of the large industries that have left behind a large number of companies with laser refraction in China. There is a way in which you can correct and make deutsch on the market consensus.